Newton is an innovation company redefining eye care through exceptional patient experiences 
and outcomes. 

Neurolens has provided life-changing relief to hundreds of thousands of patients across North America. Our innovative spirit drives us to transform eye care beyond 20/20 and pioneer new frontiers that improve patient lives and grow the optometric profession.

From this ambitious spirit, Newton was born. Named after Sir Isaac Newton — whose discoveries in the fields of mathematics, physics, astronomy, and optics revolutionized the way we understand the world — our new company commits to ground-breaking advancements that challenge conventional standards in optometry. 

At Newton, we don’t just meet expectations—
we set new ones.

Neurolenses are the world’s first and only therapeutic lenses providing life-changing relief for headaches, motion sickness and neck pain. 

Since 2012, Neurolenses with exclusive Contoured Prism™ technology have brought relief to hundreds of thousands of patients struggling with the all-too-common symptoms of eye misalignment. In fact, 90% of patients wearing Neurolenses report improvement in their symptoms.

With Neurolens, Relief is in Sight.

Sequel represents Newton’s bold expansion into comprehensive vision care solutions. Building upon over a decade of success, this portfolio expansion introduces an everyday lens that’s different from the rest. With patented Convergence Boost™ Technology, Sequel is effortless to dispense and delivers impactful results for patients experiencing visual fatigue.

We care deeply about the quality of our work

Our team is distributed across North America and Europe. What unites us is a relentless drive for innovation, fast execution, and our passion for elevating optometry through improving the lives of patients. We are all innovators at heart and care deeply about the quality of our work, down to the smallest detail.

Executive Team

Davis Corley

Chief Executive Officer

Danny Perales

Chief Operations Officer

Adwin Springer

VP Sales, North America

Nathan Schomas

Sr. VP Digital Innovation

Kaelin Currie

VP Lab Operations

Bill Kastein

VP Strategic Partnerships & Business Development

Nancy LeBosquain

VP Marketing

Zach Dios

VP Engineering

Gregory Boisse

Sr. VP Operations

Chris Cahill

VP Accounting & Finance

Board of Directors

J. Andy Corley

Chairman of the Board

Davis Corley

Director

Steve Kirby

Director

Thomas Frinzi

Director

Eric Bednarski

Director
Executive Team

Davis Corley

Chief Executive Officer

Danny Perales

Chief Operations Officer

Adwin Springer

VP Sales, North America

Nathan Schomas

Sr. VP Digital Innovation

Kaelin Currie

VP Lab Operations

Bill Kastein

VP Strategic Partnerships & Business Development

Nancy LeBosquain

VP Marketing

Zach Dios

VP Engineering

Gregory Boisse

Sr. VP Operations

Chris Cahill

VP Accounting & Finance

J. Andy Corley

Chairman of the Board

Davis Corley

Director

Steve Kirby

Director

Thomas Frinzi

Director

Eric Bednarski

Director

News

Davis Corley

Chief Executive Officer

Davis Corley co-founded Neurolenses in 2012 leading the company from early stage development to full commercialization. Under his leadership the company is creating a new category of spectacle lenses that not only provide excellent vision but also provide symptom relief for patients who suffer from excessive near work. He began his career at McGladrey, LLP, a CPA firm with the intent of gaining a wide array of business processes and financial discipline. During his time at McGladrey he completed his CPA with distinction as a senior associate of McGladrey. In 2010 he joined a group of Silicon Valley and San Diego based serial entrepreneurs where he focused on company incubation, fund raising, and operations. Davis formerly held the CPA designation, holds a master’s degree in Financial Management and Accounting from the University of San Diego as well as his bachelor’s in accounting. 

We are an innovation company redefining the eye exam through exceptional patient experiences and outcomes.

Every exceptional patient outcome writes a new chapter in our story.